- (a) For each client participating in withdrawal management, the OTP shall administer methadone/buprenorphine in a way designed for the client to reach an opioid-free state and to make progress in the ASAM Criteria (2013), available as noted in Appendix A, domains within a period of up to 180 days.
- (b) All requirements of He-A 304.23 through He-A 304.25 for treatment shall apply to withdrawal management.
- (c) Before a withdrawal management program is repeated, the licensed practitioner shall document in the client’s record that the client continues to be or is again physiologically dependent on opioids.
- (d) Withdrawal management shall not be repeated unless a licensed practitioner documents in the client’s record that the client continues to be or is again physiologically dependent on opioids; and
- (e) Repetition of withdrawal management episodes shall be determined in accordance with 42 CFR Part 8.
Source. #12476, eff 2-16-18 (formerly He-A 304.06)